Effects of different catheter replacement methods on catheter service time and complications in hemodialysis patients: A cohort study

Introduction: Central venous catheter insertion for long-term vascular access is not recommended in clinical practice. However, since arteriovenous fistula creation is difficult to perform in some patients, central venous catheter insertion for long-term vascular access is performed. This study aimed to assess the complications and service time of central venous catheters replaced using different methods and to determine the influencing factors of service time. Methods: Study design: A retrospective observational cohort study. Setting and participants: Patients who underwent tunneled dialysis catheter malfunction (2009–2019) and had to undergo another dialysis catheter insertion were enrolled. Exposures: Ectopic replacement and in situ replacement. Outcomes: Factors such as age, sex, primary patency rate, secondary patency rate, early complications, and late complications were considered. Analytical approach: This study used a Cox proportional hazards regression model. Results: The first and the newly replaced catheter service time were 37.779 ± 24.563 months and 32.468 ± 26.638 (25) months in the ectopic group and 37.075 ± 20.550 months and 26.349 ± 22.672 months in the in situ group, respectively. In the early service time, the newly replaced catheter resulted in significant bleeding from the tunnel. The first catheter had the least complications, most adequate blood flow, and longest service time. Ectopic catheter replacement and the tip shape of the catheter were the independent factors for catheter service time. Catheter service time increased with age. Conclusion: Ectopic catheter replacement can improve the primary patency rate and auxiliary primary patency rate of catheters. Ectopic catheter replacement may require sufficient surgical skills with digital subtraction angiography, resulting in a better prognosis.

Download Full-text

Langzeitergebnisse der systemischen Thrombolysetherapie bei aorto-iliakaler Verschlusskrankheit

VASA ◽

10.1024/0301-1526.30.3.212 ◽

2001 ◽

Vol 30 (3) ◽

pp. 212-218

Author(s):

Robert A. Bucek ◽

G. Schnürer ◽

M. Haumer ◽

M. Reiter ◽

A. Ahmadi ◽

...

Keyword(s):

Patency Rate ◽

Clinical Success ◽

Prospective Trial ◽

Transluminal Angioplasty ◽

Primary Patency ◽

Occlusive Disease ◽

Long Term Results ◽

Primary Patency Rate ◽

Lysis Therapy

Background: Long term results of systemic lysis therapy with ultrahigh-dose urokinase (UHUK) in reopening aorto-iliac occlusive disease have not yet been evaluated. This prospective trial investigates the long-term primary patency rate, the rate of complications and assesses the role of different expected influence parameters on the primary patency rate. Patients and methods: 72 patients with aorto-iliac occlusive disease received daily intravenous infusions of UHUK either until reperfusion or – after at least 3 cycles – no progress in recanalization could be stated on two consecutive days by duplex scanning. Results: Systemic lysis therapy was morphological at least partially successful in 44 patients (61.1%). Concomitant percutaneous transluminal angioplasty was performed in 41 patients (56.9%), surgery in 7 patients (9.7%) and both in further 5 patients (6.9%). In patients without surgery hemodynamical success could be achieved in 39 patients (54.2%) and even more important clinical success in 51 patients (70.8%). Compared to baseline results patients improved significantly in ankle/brachial pressure index and in Fontaine stages (p < 0,001), the same results could be seen after a mean follow-up period of 62 months. Thrombolysis was complicated in 4 patients (5.6%) by macroembolizations but no major bleedings or deaths occurred. Primary patency was 76%, 64%, and 43% after 1, 5 and 10 years. Male sex and distal localization were significantly correlated with lower primary clinical patency. Conclusion: Systemic lysis therapy is an alternative to surgical intervention in acute and subacute aorto-iliac occlusive disease, because it offers acceptable long-term results with a low rate of complications.

Download Full-text

The Long-term Impact of Simulation-Based Training for Central Venous Catheter Insertion

CHEST Journal ◽

10.1378/chest.1988518 ◽

2014 ◽

Vol 146 (4) ◽

pp. 492A

Author(s):

Laura Thomas ◽

Jonathan Mahnken ◽

Sally Rigler ◽

Matthew Sharpe ◽

Emily Diederich

Keyword(s):

Central Venous Catheter ◽

Venous Catheter ◽

Catheter Insertion ◽

Central Venous Catheter Insertion ◽

Central Venous ◽

Simulation Based ◽

Long Term Impact

Download Full-text

Comparison of Management for Central Venous Stenosis With or Without Previous Catheter Placement

Frontiers in Neurology ◽

10.3389/fneur.2021.703286 ◽

2021 ◽

Vol 12 ◽

Author(s):

Wei Ma ◽

Zhengde Zhao ◽

Qining Fu ◽

Liangzhu Hu ◽

Xia Zhao ◽

...

Keyword(s):

Patency Rate ◽

Bare Metal Stent ◽

Primary Patency ◽

Catheter Placement ◽

Bare Metal ◽

Metal Stent ◽

Central Venous ◽

Primary Patency Rate ◽

Central Venous Stenosis ◽

Venous Stenosis

Objective: To compare central venous stenosis/occlusion with or without previous jugular catheter placement history.Methods: Data of patients with central vein stenosis/occlusion receiving endovascular intervention in our hospital from January 2015 to December 2018 were collected and analyzed.Results: Twenty-nine patients with previous jugular catheter placement history (CVC group) and 33 patients (excluded two with technical failure) without such history (non-CVC group) are included in this study. Previous jugular catheter placement history raised the risk of postintervention recurrence 1.02 times (CVC group vs. non-CVC group, HR = 2.02 95%CI: 0.91–4.48). The primary patency rate at 6, 12, 18, and 24 months was 76.9, 54.2, 45.5, and 25.0% separately in the CVC group and 80.6, 70.0, 67.9, and 44.4% separately in the non-CVC group. The assisted primary patency rate at 6, 12, 18, and 24 months was 92.3, 91.7, 86.4, and 68.8% separately in the CVC group and 93.5, 90.0, 82.1, and 61.1% separately in the non-CVC group. Patients in the CVC group received a higher frequency of reintervention (0.7 times/year/patient vs. 0.3 times/year/patient). There was no significant difference in the assisted primary patency rate between the two groups. Different primary interventions (angioplasty alone, bare metal stent, stent graft) did not affect primary patency and assisted primary patency, but percutaneous transluminal stenting (PTS) with a bare metal stent had a significant lower primary patency rate between 3 and 24 months compared with PTS with a stent graft (p = 0.011).Conclusion: Central venous stenosis/occlusion with a previous jugular catheter placement history develops symptoms earlier and had a worse prognosis after endovascular intervention. More efforts are needed to carry out end-stage kidney disease life plan to reduce the harm of evitable catheter placement.

Download Full-text

LB004-SUN CENTRAL VENOUS CATHETER REPLACEMENT IN 27 PAEDIATRIC PATIENTS ON LONG TERM PARENTERAL NUTRITION: 116 PATIENT YEARS OF EXPERIENCE

Clinical Nutrition Supplements ◽

10.1016/s1744-1161(12)70625-7 ◽

2012 ◽

Vol 7 (1) ◽

pp. 252

Author(s):

K. Dimakou ◽

J. Ish-Horowicz ◽

S. Hill

Keyword(s):

Central Venous Catheter ◽

Parenteral Nutrition ◽

Venous Catheter ◽

Years Of Experience ◽

Central Venous ◽

Paediatric Patients ◽

Catheter Replacement

Download Full-text

Endovascular treatment for chronic atherosclerotic occlusive mesenteric disease: Is stenting superior to balloon angioplasty?

VASA ◽

10.1024/0301-1526/a000056 ◽

2010 ◽

Vol 39 (4) ◽

pp. 319-324 ◽

Cited By ~ 9

Author(s):

Daliri ◽

Grunwald ◽

Jobst ◽

Szucs-Farkas ◽

Diehm ◽

...

Keyword(s):

Endovascular Treatment ◽

Patency Rate ◽

Celiac Artery ◽

Primary Patency ◽

Secondary Patency ◽

Chronic Mesenteric Ischemia ◽

Primary Patency Rate ◽

Secondary Patency Rate

Background: Endovascular treatment is an increasingly used therapeutic option in patients with chronic atherosclerotic occlusive mesenteric disease. Purpose of this study was evaluation of patency and mortality in patients treated with visceral artery percutaneous transluminal angioplasty (PTA) or stenting including follow-up. Patients and methods: A retrospective review of 17 consecutive patients (4 women, 13 men) with endovascular treatment for symptomatic chronic mesenteric ischemia from 1998 to 2004 was performed. Mean follow-up period was 42 months. Patient demographics, interventional details, primary and/or secondary patency and mortality were recorded. Cumulative mortality and patency rates were determined using Kaplan-Meier life table analysis. Results: Twenty-six interventions (PTA alone n = 13, PTA and stenting n = 13) were performed in 17 patients. Interventions were performed in the superior mesenteric artery (n = 13) and celiac artery (n = 13). The re-intervention rate was 30 % (6/26). Re-interventions were performed for the superior mesenteric artery (n = 4) and celiac artery (n = 2). Cumulative overall 1-year results were primary patency rate 81 %, secondary patency rate 94 %, and survival rate 82 %. Cumulative 10-year results were primary patency rate 73 %, secondary patency rate 94 %, and survival rate 65 %. The 10-year secondary patency rate was 100 % in patients post initial stenting and 86 % in patients post initial PTA. Conclusions: Long-term follow-up post endovascular treatment for chronic mesenteric ischemia demonstrated a considerable overall secondary patency rate of 94 %. However, the long-term secondary patency rate was higher in patients post initial stenting compared to PTA alone.

Download Full-text